Who is sponsoring NCT05771467?

NCT05771467 is sponsored by Akdeniz University.

What drugs are being tested in NCT05771467?

Interventions in NCT05771467: Comprehensive Ophthalmologic Examination.

What condition does NCT05771467 study?

NCT05771467 studies Eye Injury Trauma.

Is NCT05771467 still recruiting?

NCT05771467 is currently completed. Last updated 16 January 2025.

Are results published for NCT05771467?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-01-16 · How we verify

NCT05771467

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Retinal Microvascular Change That May Develop in After Open Globe Injury

Completed Results posted Last updated 16 January 2025

What this trial tests

trial testing Comprehensive Ophthalmologic Examination in Eye Injury Trauma in 100 participants. Completed in 2 September 2024.

Timeline

2 March 2024

Primary endpoint
2 September 2024

2 September 2024

Quick facts

Lead sponsor	Akdeniz University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	2 March 2024
Primary completion	2 September 2024
Estimated completion	2 September 2024
Sites	2 locations across Turkey (Türkiye)

Drugs / interventions tested

Comprehensive Ophthalmologic Examination

Conditions studied

Eye Injury Trauma — all drugs for Eye Injury Trauma →

Sponsor

Akdeniz University

Who can join

18 and older, any sex, with Eye Injury Trauma. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Corneal Thickness Primary · 10 minutes

Corneal thickness in mikrometer value

Group	Value	95% CI
Trauma Group	542.23	± 27.47
Control Group	546.16	± 46.03
Total Group	544.32	± 35.3

Anterior Chamber Volume Primary · 10 minutes

Anterior chamber volume in mm3

Group	Value	95% CI
Trauma Group	177.97	± 28.46
Control Group	165.9	± 26.73

Anterior Chamber Depth Primary · 10 minutes

Anterior chamber depth in mm

Group	Value	95% CI
Trauma Group	2.93	± 0.25
Control Group	3.05	± 0.29

Anterior Chamber Angle Primary · 10 minutes

Anterior chamber angle in degree

Group	Value	95% CI
Trauma Group	38.87	± 6.42
Control Group	37.8	± 4.74

Lens Power Primary · 10 minutes

in diopters

Group	Value	95% CI
Trauma Group	20.98	± 0.35
Control Group	20.26	± 0.44

Steep Keratometry Primary · 10 minutes

in Diopters measured with pentacam

Group	Value	95% CI
Trauma Group	44.22	± 1.64
Control Group	44.57	± 1.82

Tonometry Primary · 10 minutes

Intraocular pressure measurement in mmHg

Group	Value	95% CI
Trauma Group	14.74	± 0.49
Control Group	15.78	± 0.35

Axial Length Primary · 10 minutes

Axial length in mm

Group	Value	95% CI
Trauma Group	23.86	± 0.94
Control Group	23.36	± 0.72

Optic Nerve Head Vessel Density Primary · 10 minutes

Optic nerve head vessel density assessed with optical coherence tomography angiography

Group	Value	95% CI
Trauma Group	23.22	± 5.2
Control Group	25.2	± 4.4

Choriocapillaris Flow Area Primary · 10 minutes

Choriocapillaris flow area assessed with optical coherence tomography angiography

Group	Value	95% CI
Trauma Group	36.88	± 1.52
Control Group	36.53	± 1.89

Subfoveal Central Macular Thickness Primary · 10 minutes

Subfoveal central macular thickness assessed with optical coherence tomography

Group	Value	95% CI
Trauma Group	321.42	± 24.52
Control Group	311.57	± 31.13

Sponsor's own description

The aim of this study is to evaluate posterior segment changes in the non-traumatic eye after open globe injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Comprehensive Ophthalmologic Examination

Trials testing the same drug.

NCT05175729 — Comparing Anterior Segment Parameters During Pregnancy and Post-Pregnancy · completed

Other Akdeniz University trials

Trials by the same sponsor.

NCT07581132 — Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients · NA · not yet recruiting
NCT07469345 — Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men · enrolling by invitation
NCT07507279 — Technology-based Hand Rehabilitation in Older People · NA · not yet recruiting
NCT07437924 — Bruxism and Pelvic Floor Dysfunction in Young Women · enrolling by invitation
NCT07497308 — GDF-15 and Early Outcomes After LVAD Implantation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05771467 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Akdeniz University
Last refreshed: 16 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05771467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing